[HTML][HTML] Brain health: time matters in multiple sclerosis

G Giovannoni, H Butzkueven, S Dhib-Jalbut… - Multiple sclerosis and …, 2016 - Elsevier
Introduction We present international consensus recommendations for improving diagnosis,
management and treatment access in multiple sclerosis (MS). Our vision is that these will be …

Smoke and autoimmunity: The fire behind the disease

C Perricone, M Versini, D Ben-Ami, S Gertel… - Autoimmunity …, 2016 - Elsevier
The association between smoke habit and autoimmunity has been hypothesized a long time
ago. Smoke has been found to play a pathogenic role in certain autoimmune disease as it …

Association between cigarette smoking and multiple sclerosis: a review

M Rosso, T Chitnis - JAMA neurology, 2020 - jamanetwork.com
Importance Cigarette smoking is a common environmental exposure and addiction, which
has severe health consequences. Smoking is a risk factor for multiple sclerosis (MS); also …

Etiology, effects and management of comorbidities in multiple sclerosis: recent advances

RA Marrie, JD Fisk, K Fitzgerald, K Kowalec… - Frontiers in …, 2023 - frontiersin.org
Comorbid conditions commonly affect people with multiple sclerosis (MS). Population-based
studies indicate that people with MS have an increased incidence of ischemic heart disease …

A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications

L Hauer, J Perneczky, J Sellner - Journal of Neurology, 2021 - Springer
Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system
which is associated with numerous comorbidities. These include cardiovascular disease …

Infections in patients diagnosed with multiple sclerosis: a multi-database study

R Persson, S Lee, MU Yood, CM Wagner… - Multiple sclerosis and …, 2020 - Elsevier
Background Recent data on the rates of infections among patients with multiple sclerosis
(MS) are sparse. The objective of this study was to quantify incidence of infections in patients …

[HTML][HTML] Infections in patients with multiple sclerosis: A national cohort study in Sweden

A Castelo-Branco, F Chiesa, S Conte… - Multiple sclerosis and …, 2020 - Elsevier
Background Multiple sclerosis (MS) patients have an increased risk of infections, but few
population-based studies have reported infections occurring in MS in the years immediately …

[HTML][HTML] Wellness and the role of comorbidities in multiple sclerosis

BP Moss, MR Rensel, CM Hersh - Neurotherapeutics, 2017 - Elsevier
Multiple sclerosis (MS) is a demyelinating and neurodegenerative disorder of the central
nervous system, for which disease modifying therapies (DMTs) are the mainstay treatment …

Glycomic analysis of host response reveals high mannose as a key mediator of influenza severity

DW Heindel, S Koppolu, Y Zhang… - Proceedings of the …, 2020 - National Acad Sciences
Influenza virus infections cause a wide variety of outcomes, from mild disease to 3 to 5
million cases of severe illness and∼ 290,000 to 645,000 deaths annually worldwide. The …

Modifiable risk factors for multiple sclerosis have consistent directions of effect across diverse ethnic backgrounds: a nested case–control study in an English …

BM Jacobs, P Tank, JP Bestwick, AJ Noyce… - Journal of …, 2024 - Springer
Background Multiple sclerosis is a leading cause of non-traumatic neurological disability
among young adults worldwide. Prior studies have identified modifiable risk factors for …